Dyne Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 4 | -$0.80 | -$0.80 | -$0.80 |
| Q2 2024 | 2 | -$0.72 | -$0.72 | -$0.72 |
| Q3 2024 | 2 | -$0.71 | -$0.71 | -$0.71 |
| Q4 2024 | 7 | -$1.10 | -$0.70 | -$0.93 |
| Q1 2025 | 4 | -$1.03 | -$0.71 | -$0.87 |
| Q2 2025 | 2 | -$0.92 | -$0.92 | -$0.92 |
| Q3 2025 | 2 | -$0.93 | -$0.93 | -$0.93 |
| Q4 2025 | 2 | -$0.97 | -$0.97 | -$0.97 |
Dyne Therapeutics, Inc. Earnings Date And Information
Dyne Therapeutics, Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.96 earnings per share for the quarter, missing analysts' consensus estimates of $-0.71 by $0.25. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Dyne Therapeutics, Inc. has generated $-4 earnings per share over the last year ($-3.95 diluted earnings per share) and currently has a price-to-earnings ratio of -10.17. Dyne Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2025 based on prior year's report dates.
Dyne Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | -$0.96 | $0 | $0 | ||
| 08/12/2024 | Q2 2024 | -$0.72 | -$0.70 | 0.02 | $0 | $0 |
| 05/02/2024 | Q1 2024 | -$0.81 | -$0.81 | 0 | $0 | |
| 03/05/2024 | Q4 2023 | -$0.92 | -$1.09 | -0.17 | $3.79 M | |
| 10/30/2023 | Q3 2023 | -$0.86 | -$0.99 | -0.13 | $0 | |
| 08/03/2023 | Q2 2023 | -$0.81 | -$1.08 | -0.27 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.77 | -$0.75 | 0.02 | $0 | |
| 03/02/2023 | Q4 2022 | -$0.84 | -$0.71 | 0.13 | $0 | |
| 11/03/2022 | Q3 2022 | -$0.95 | -$0.78 | 0.17 | $0 | |
| 08/04/2022 | Q2 2022 | -$0.79 | -$1.01 | -0.22 | $0 | |
| 05/02/2022 | Q1 2022 | -$0.88 | -$0.69 | 0.19 | $0 | |
| 03/10/2022 | Q4 2021 | -$0.99 | -$1.00 | -0.01 | $0 | |
| 11/04/2021 | Q3 2021 | -$0.65 | -$0.83 | -0.18 | $0 | |
| 08/05/2021 | Q2 2021 | -$0.55 | -$0.58 | -0.03 | $0 | |
| 05/06/2021 | Q1 2021 | -$0.60 | -$0.50 | 0.1 | $0 | |
| 03/04/2021 | Q4 2020 | -$0.38 | -$0.64 | -0.26 | $0 | |
| 11/05/2020 | Q3 2020 | -$0.87 | -$0.31 | 0.56 | $0 | |
| 06/29/2020 | Q2 2020 | -$0.22 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.62 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.42 | $0 |
Dyne Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Dyne Therapeutics, Inc.'s earnings date?
Dyne Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2025 based off last year's report dates.
-
How can I listen to Dyne Therapeutics, Inc.'s earnings conference call?
The conference call for Dyne Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Dyne Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Dyne Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Dyne Therapeutics, Inc. generate each year?
Dyne Therapeutics, Inc. (:DYN) has a recorded net income of $0. Dyne Therapeutics, Inc. has generated $-3.95 earnings per share over the last four quarters.
-
What is Dyne Therapeutics, Inc.'s price-to-earnings ratio?
Dyne Therapeutics, Inc. (:DYN) has a price-to-earnings ratio of -10.17 and price/earnings-to-growth ratio is -12.17.
